Janux Therapeutics Inc (JANX)

Janux Therapeutics Inc (JANX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.1B; returns 1 day -2.3%, 1 week +0.9%, 1 year -31.9%.

Janux Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies for cancer and autoimmune diseases. The company's business model is centered on its proprietary technology platforms: Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM).

Groups JANX belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Cancer Therapeutics
• Immunotherapy
• Biopharmaceutical
• Life Sciences
• Antibody Therapeutics
• Healthcare

JANX financial model: income statement, cash flow and balance sheet